Additionally, its indications have been expanded to include epithelial and stromal corneal dystrophies such as lattice and granular corneal dystrophy, which are associated with mutations in the transforming growth factor beta-induced (TGFBI) gene. The gene discussed is TGFBI; the disease is Granular corneal dystrophy.